News

Medidata has launched its new eConnect Partner Program.

TKL Research, a dermatology specialty clinical research organization, has agreed to sell its Clinical Trials Division to QuintilesIMS.

Vendor oversight in clinical trials is a subject not often discussed despite a disconnect in how it is carried out between multiple departments. Celeste Gonzalez of Boston Scientific shares her perspectives on the subject.

Clinerion announces a new service for use with its Patient Recruitment System (PRS).

Gamification is the application of game design principles and techniques to non-game contexts intending to create value for players and stakeholders alike. If applied, this principle can potentially drive greater innovation and efficiencies in clinical research.

Bracket announced the acquisition of international software development and consulting firm CLINapps Inc.

Comprehend recently released a survey of over 100 Clinical Operations leaders providing consensus on their goals, challenges and best practices for CRO Oversight.

DrugDev has announced the acquisition of SecureConsent, a provider of electronic informed consent solutions.

TransCelerate’s recently published article in a DIA publication covered issues management in clinical trial Quality Management Systems (QMS). Abbvie’s Susan Callery-D’Amico speaks to us about TransCelerate’s QMS Initiative and Issue Management.

Have the roles of the monitor advanced? How are CRAs accepting the change? How is pharma implementing RBM-is it more remote, centralized or a combination? How important is eSource to RBM? This eBook will highlight articles that answer these question.

The Biologics Prescribers Collaborative has released findings from a physician’s survey about the FDA’s proposed biosimilar naming guidelines.

A new analysis conducted by the Tufts Center for the Study of Drug Development reports that the outlook for greater pediatric drug development is promising.

The European Medicines Agency (EMA) has released an update on its plans to revise the existing guideline on first-in-human clinical trials.

The Society for Clinical Research Sites (SCRS) has announced GlaxoSmithKline (GSK) as its newest Global Impact Partner (GIP).

Schulman IRB and iMedRIS Data Corporation announce a partnership to provide research organizations with integrated technology, consulting and IRB review services.

The American Heart Association (AHA) has announced the launch of a cloud-based Precision Medicine Platform in collaboration with Amazon Web Services (AWS).